Literature DB >> 17244710

Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury.

Li Zhu1, Wolfgang Bergmeier, Jie Wu, Hong Jiang, Timothy J Stalker, Marcin Cieslak, Ran Fan, Laurence Boumsell, Atsushi Kumanogoh, Hitoshi Kikutani, Luca Tamagnone, Denisa D Wagner, Marcos E Milla, Lawrence F Brass.   

Abstract

Semaphorin 4D (sema4D; CD100) is an integral membrane protein and the ligand for two receptors, CD72 and plexin-B1. Soluble sema4D has been shown to evoke angiogenic responses from endothelial cells and impair monocyte migration, but the origin of soluble sema4D, particularly at sites of vascular injury, has been unclear. Here we show that platelets express sema4D and both of its receptors and provide evidence that these molecules promote thrombus formation. We also show that the surface expression of sema4D and CD72 increases during platelet activation, followed by the gradual shedding of the sema4D extracellular domain. Shedding is blocked by metalloprotease inhibitors and abolished in mouse platelets that lack the metalloprotease ADAM17 (TACE). Mice that lack sema4D exhibit delayed arterial occlusion after vascular injury in vivo, and their platelets show impaired collagen responses in vitro. In resting platelets, as in B lymphocytes, CD72 is associated with the protein tyrosine phosphatase SHP-1. Platelet activation causes dissociation of the complex, as does the addition of soluble sema4D. These findings suggest a dual role for sema4D in vascular responses to injury. As thrombus formation begins, platelet-associated sema4D can bind to its receptors on nearby platelets, promoting thrombus formation. As thrombus formation continues, sema4D is shed from the platelet surface and becomes available to interact with receptors on endothelial cells and monocytes, as well as continuing to interact with platelets.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244710      PMCID: PMC1785259          DOI: 10.1073/pnas.0606344104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  The CD100-CD72 interaction: a novel mechanism of immune regulation.

Authors:  A Kumanogoh; H Kikutani
Journal:  Trends Immunol       Date:  2001-12       Impact factor: 16.687

Review 2.  Controlling the immune system through semaphorins.

Authors:  Georges Bismuth; Laurence Boumsell
Journal:  Sci STKE       Date:  2002-04-16

3.  Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred.

Authors:  Nicolas Prevost; Donna Woulfe; Takako Tanaka; Lawrence F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

4.  Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis.

Authors:  John R Basile; Rogerio M Castilho; Vanessa P Williams; J Silvio Gutkind
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

5.  Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration.

Authors:  S Delaire; C Billard; R Tordjman; A Chédotal; A Elhabazi; A Bensussan; L Boumsell
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

6.  Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses.

Authors:  X Wang; A Kumanogoh; C Watanabe; W Shi; K Yoshida; H Kikutani
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

7.  The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice.

Authors:  W Shi; A Kumanogoh; C Watanabe; J Uchida; X Wang; T Yasui; K Yukawa; M Ikawa; M Okabe; J R Parnes; K Yoshida; H Kikutani
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

8.  The plexin-B1/Rac interaction inhibits PAK activation and enhances Sema4D ligand binding.

Authors:  Haris G Vikis; Weiquan Li; Kun-Liang Guan
Journal:  Genes Dev       Date:  2002-04-01       Impact factor: 11.361

9.  CD40L stabilizes arterial thrombi by a beta3 integrin--dependent mechanism.

Authors:  Patrick André; K S Srinivasa Prasad; Cécile V Denis; Ming He; Jessie M Papalia; Richard O Hynes; David R Phillips; Denisa D Wagner
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

10.  Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology.

Authors:  Jakub M Swiercz; Rohini Kuner; Jürgen Behrens; Stefan Offermanns
Journal:  Neuron       Date:  2002-07-03       Impact factor: 17.173

View more
  82 in total

Review 1.  Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.

Authors:  Atsuko Sakurai; Colleen L Doçi; Colleen Doci; J Silvio Gutkind
Journal:  Cell Res       Date:  2011-12-13       Impact factor: 25.617

Review 2.  Semaphorins in angiogenesis and tumor progression.

Authors:  Gera Neufeld; Adi D Sabag; Noa Rabinovicz; Ofra Kessler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 3.  Arterial thrombosis--insidious, unpredictable and deadly.

Authors:  Shaun P Jackson
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

4.  Deciphering the human platelet sheddome.

Authors:  Karen P Fong; Colin Barry; Anh N Tran; Elizabeth A Traxler; Kenneth M Wannemacher; Hsin-Yao Tang; Kaye D Speicher; Ian A Blair; David W Speicher; Tilo Grosser; Lawrence F Brass
Journal:  Blood       Date:  2010-10-20       Impact factor: 22.113

Review 5.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

6.  Enhanced potency of the metalloprotease inhibitor TAPI-2 by multivalent display.

Authors:  Aram J Raissi; Frank A Scangarello; Kaitlin R Hulce; Jason K Pontrello; Suzanne Paradis
Journal:  Bioorg Med Chem Lett       Date:  2014-02-14       Impact factor: 2.823

7.  Tax and Semaphorin 4D Released from Lymphocytes Infected with Human Lymphotropic Virus Type 1 and Their Effect on Neurite Growth.

Authors:  Sebastián Quintremil; Carolina Alberti; Matías Rivera; Fernando Medina; Javier Puente; Luis Cartier; Eugenio Ramírez; Yuetsu Tanaka; M Antonieta Valenzuela
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-21       Impact factor: 2.205

Review 8.  Systems biology of platelet-vessel wall interactions.

Authors:  Yolande Chen; Seth Joel Corey; Oleg V Kim; Mark S Alber
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

9.  p38 mitogen-activated protein kinase activation during platelet storage: consequences for platelet recovery and hemostatic function in vivo.

Authors:  Matthias Canault; Daniel Duerschmied; Alexander Brill; Lucia Stefanini; Daphne Schatzberg; Stephen M Cifuni; Wolfgang Bergmeier; Denisa D Wagner
Journal:  Blood       Date:  2009-11-30       Impact factor: 22.113

10.  Platelet IκB kinase-β deficiency increases mouse arterial neointima formation via delayed glycoprotein Ibα shedding.

Authors:  Shujian Wei; Huan Wang; Guoying Zhang; Ying Lu; Xiaofei An; Shumei Ren; Yunmei Wang; Yuguo Chen; James G White; Chunxiang Zhang; Daniel I Simon; Chaodong Wu; Zhenyu Li; Yuqing Huo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.